Organon (OGN) Change in Intangibles (2021 - 2025)

Organon (OGN) recorded quarterly Change in Intangibles of $69.0 million in Q3 2025, up 25.45% quarter-over-quarter from $55.0 million in Q1 2025, and up 200.0% on a YoY basis from $23.0 million in Q3 2024.

Organon (OGN) Change in Intangibles (2021 - 2025) Analysis & Trends

Organon's Change in Intangibles history runs 5 years deep, the most recent figure standing at $69.0 million for Q3 2025.

  • In Q3 2025, Change in Intangibles rose 200.0% year-over-year to $69.0 million; the TTM figure through Mar 2026 stood at $69.0 million (down 37.27% YoY), while the FY2025 annual figure was $124.0 million, up 18.1% from the prior year.
  • Change in Intangibles was $69.0 million for Q3 2025 at Organon, up from $55.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $192.0 million in Q2 2021 to a low of $2.0 million in Q4 2023.
  • Historically, Change in Intangibles has averaged $51.0 million across 5 years, with a median of $35.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Change in Intangibles tumbled 79.69% in 2022, then jumped 1500.0% in 2024.
  • A 5-year view of Change in Intangibles shows it stood at $192.0 million in 2021, then tumbled by 90.62% to $18.0 million in 2022, then sank by 88.89% to $2.0 million in 2023, then surged by 1500.0% to $32.0 million in 2024, then jumped by 115.62% to $69.0 million in 2025.
  • The last three Change in Intangibles figures came in at $69.0 million (Q3 2025), $55.0 million (Q1 2025), and $32.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -299.30 Mn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn -
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 69.00 Mn
Sep 30, 2025 69.00 Mn
Mar 31, 2025 55.00 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 32.00 Mn
Dec 31, 2024 32.00 Mn
Sep 30, 2024 23.00 Mn
Sep 30, 2024 23.00 Mn
Mar 31, 2024 50.00 Mn
Mar 31, 2024 50.00 Mn
Dec 31, 2023 2.00 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2022 18.00 Mn
Sep 30, 2022 18.00 Mn
Jun 30, 2022 39.00 Mn
Jun 30, 2022 39.00 Mn
Mar 31, 2022 30.00 Mn
Mar 31, 2022 30.00 Mn
Jun 30, 2021 192.00 Mn
Jun 30, 2021 192.00 Mn